Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Balanced slat solution		Theatre use
Balsalazide		Consultant initiation - only when other agents have been ineffective
Bambuterol tablets		Specialist initiation for severe brittle asthma / CF
Baricitinib (Olumiant®)	TA466 - Baricitinib for moderate to severe rheumatoid arthritis	Hospital use only
Basiliximab injection		For hospital use only
BCG bladder instillation		For hospital use only
Beclometasone and formoterol (Fostair® NEXThaler®)		Fostair Aerosol inhalation - Beclometasone dipropionate 100 micrograms & Formoterol fumarate 6 micrograms Fostair Aerosol inhalation - Beclometasone dipropionate 200 micrograms & Formoterol fumarate 6 micrograms Fostair NEXThaler® (= dry powder inhalation) - Beclometasone dipropionate 100 micrograms & Formoterol fumarate 6 micrograms Fostair NEXThaler® (= dry powder inhalation) - Beclometasone dipropionate 200 micrograms & Formoterol fumarate 6 micrograms
Beclometasone and formoterol (Fostair®)		Fostair Aerosol inhalation - Beclometasone dipropionate 100 micrograms & Formoterol fumarate 6 micrograms Fostair Aerosol inhalation - Beclometasone dipropionate 200 micrograms & Formoterol fumarate 6 micrograms Fostair NEXThaler® (= dry powder inhalation) - Beclometasone dipropionate 100 micrograms & Formoterol fumarate 6 micrograms Fostair NEXThaler® (= dry powder inhalation) - Beclometasone dipropionate 200 micrograms & Formoterol fumarate 6 micrograms
Beclometasone CFC free MDI (QVAR brand)	TA138 - Asthma (in adults) - corticosteroids	For existing patients only
Beclometasone dipropionate		APC listing of current formulary brands

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.